Viatris Inc. director David S. Simmons reported an insider acquisition tied to his board compensation, not an open-market stock purchase or sale. On June 30, 2026, Simmons was automatically granted 2,362 deferred stock units, or DSUs, after electing to receive his quarterly non-employee director fees in equity rather than cash. The grant was valued using Viatris’ June 30 closing stock price of $15.88 per share. The transaction was reported on Form 4 filed July 1, 2026. The DSUs are derivative securities, with each unit representing the right to receive one share of Viatris common stock. The filing describes the award as fully vested at grant. Settlement will occur in Viatris common shares upon the earliest of Simmons’ termination of service as a non-employee director, his death or disability, or a change in control of the company. The reported transaction code is consistent with an acquisition of securities through an issuer compensation arrangement. Because the DSUs were granted in lieu of cash director fees, the filing does not indicate that Simmons bought shares in the market or sold any Viatris securities. Following the reported transaction, the filing reflects beneficial ownership of 2,362 DSUs associated with this award. The filing was signed on Simmons’ behalf by Kevin Macikowski under power of attorney on July 1, 2026.
Stock detail
Viatris (VTRS) stock price, chart, and key data
View Viatris stock price, chart movement, and headline metrics on Woodstock's stock detail page.

Stock detail
Viatris
VTRS · XNAS
-$0.75 (-4.39%) past day
$16.34
Overnight $16.27 (-0.43%)
Key metrics
Earnings
Quarterly results and the next expected release
FY25 Q2
Q3
Q4
FY26 Q1
Q2
Q3
Dividend
Past Dividend Performance
$0.12
$0.12
$0.12
Annual Dividend Yield
2.94%
Dividend
$0.12 / Stock
Frequency
Quarterly Payment
Day range
$16.77 - $17.45
52-week range
$8.63 - $17.68
Close price
$17.28
Market cap
$20.1B
P/E ratio
-62.86
Beta
0.91
About the company
Viatris Inc.
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue.
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Ro Khanna
democrat · House · CA-17
- Sell$1,000 / $8,000 / $15,000
- Buy$1,000 / $8,000 / $15,000
- Sell$1,000 / $8,000 / $15,000
- Buy$1,000 / $8,000 / $15,000
#2Rob Bresnahan
republican · House · PA-8
- Sell$1,001 / $8,001 / $15,000
- Buy$1,000 / $8,000 / $15,000
#3Ro Khanna
democrat · House · CA-17
- Sell$1,000 / $8,000 / $15,000
#4Ro Khanna
democrat · House · CA-17
- Buy$1,000 / $8,000 / $15,000
#5Gilbert Cisneros
democrat · House · CA-31
- Buy$1,001 / $8,001 / $15,000
- Sell$1,000 / $8,000 / $15,000
#6Laura Friedman
democrat · House · CA-30
#7Debbie Wasserman Schultz
democrat · House
#8James French Hill
republican · House · AR-2
#9Michael Burgess
republican · House · TX-26
#10Donald J Trump
republican · Executive
Market action
A concise summary of the latest filing, transaction, or market-moving item.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app